Souhaitez-vous accéder aux communiqués récents ?

IGEL and Microsoft release secure cloud desktop blueprints for Windows 365 and Azure Virtual Desktop across healthcare, government, and contact centers.

UREVO launches AI-powered recovery stations at USASA 2026 with smart recovery boots, massage tech and athlete support.

Potential breakthrough therapeutic targets $50B+ global immunotherapy market1 CHICAGO, March 31, 2026 (GLOBE NEWSWIRE) -- MAIA Biotechnology, Inc. (NYSE American: MAIA) (“MAIA”, the “Company”), a...

WSO2 launches an API Platform to make APIs and AI assets agent-ready, with unified governance, cost control, and no vendor lock-in.

Atlanta, GA, March 31, 2026 (GLOBE NEWSWIRE) -- OfficeSpace Software, provider of the leading AI Operating System for the Built World, today announced it has been named to the Inc. Regionals:...

HSINCHU, Taiwan, March 31, 2026 (GLOBE NEWSWIRE) -- As a global leader in display technologies and solutions, AUO leverages group‑wide strengths to continuously advance deployment across vertical...

First clinical trial conducted in human subjects to evaluate CT2000 for the treatment of both acute ocular pain and chronic ocular surface pain commonly associated with dry eye disease CT2000 is a...

Regula study: outcome-based fraud KPIs are failing. Businesses shift to proactive metrics: compliance, ROI, and real-time fraud detection.

IMNN-001 is the first frontline immunotherapy to demonstrate the potential for a clinically meaningful overall survival benefit in women newly diagnosed with advanced ovarian cancer Final Phase 2...

ARDS / hypoxemic pneumonia Phase 2 trial initiation 1H 2026; early data by year end; market opportunity of ~200,000–300,000 patients annually in US/EUC-Further Consortium collaboration adds to growing...